MENU

MRUS Merus NV Forecast, Technical & Fundamental Analysis

a developer of therapeutics for cancer treatment

Industry Biotechnology
MRUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
MRUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRUS is expected to report earnings to fall 32.79% to -98 cents per share on March 04

Merus NV MRUS Stock Earnings Reports
Q4'24
Est.
$-0.98
Q3'24
Missed
by $0.60
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.22
Q4'23
Missed
by $0.27
The last earnings report on October 31 showed earnings per share of -146 cents, missing the estimate of -86 cents. With 300.00K shares outstanding, the current market capitalization sits at 3.40B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

MRUS and Stocks

Correlation & Price change

A.I.dvisor tells us that MRUS and IMTX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRUS and IMTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-1.36%
IMTX - MRUS
33%
Poorly correlated
+1.06%
RCKT - MRUS
31%
Poorly correlated
-2.25%
NKTX - MRUS
30%
Poorly correlated
-4.59%
TNYA - MRUS
30%
Poorly correlated
-5.43%
CGEM - MRUS
29%
Poorly correlated
-1.44%
More

Groups containing MRUS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-1.36%
cancer
theme (82 stocks)
40%
Loosely correlated
-2.38%
treatment
theme (56 stocks)
39%
Loosely correlated
-1.12%
drugs
theme (254 stocks)
37%
Loosely correlated
-1.72%
therapeutics
theme (53 stocks)
29%
Poorly correlated
-2.44%
europe
theme (179 stocks)
24%
Poorly correlated
-0.25%
More